US court limits mail-order access to abortion pill mifepristone
Translated from Chinese, summarized and contextualized by DistantNews.
TLDR
- A US court has significantly restricted the mail-order access to the abortion pill mifepristone, reinstating a requirement for in-person dispensing.
- The ruling, stemming from a lawsuit by Louisiana, pauses a 2023 FDA regulation that allowed pills to be sent by mail or obtained at pharmacies via telemedicine.
- This decision impacts abortion access, particularly in states where it is already banned, and has drawn praise from anti-abortion advocates and criticism from civil liberties groups.
A significant legal battle over abortion access has taken a new turn as a US court issued an order that severely curtails the availability of mifepristone, the most common abortion pill, when prescribed via mail. The Fifth Circuit Court of Appeals has temporarily put the brakes on a 2023 FDA regulation, reverting to a requirement that patients must obtain the medication in person, effectively blocking its distribution through telemedicine and pharmacies in many areas.
Every abortion facilitated by FDA's action cancels Louisiana's ban on medical abortions and undermines its policy that 'every unborn child is human being from the moment of conception and is, therefore, a legal person.'
This decision, originating from a lawsuit filed by the state of Louisiana, directly challenges the FDA's authority and prioritizes state-level abortion bans over federal guidelines. The court's reasoning explicitly states that the FDA's actions undermine state policies protecting unborn life, framing the issue as a conflict between federal regulation and state sovereignty in matters of abortion.
I look forward to continuing to defend women and babies as this case continues.
Anti-abortion groups have hailed this ruling as a major victory. Louisiana Attorney General Liz Murrill celebrated the decision, stating it upholds the state's ban on medical abortions and protects "unborn children." Similarly, Marjorie Dannenfelser of Susan B. Anthony Pro-Life America called it a "huge victory for victims and survivors of Biden's reckless mail-order abortion drug regime."
This decision defies clear science and settled law and advances an anti-abortion agenda that is deeply unpopular with the American people.
Conversely, reproductive rights advocates and legal organizations are decrying the decision as a blow to established law and medical science. The American Civil Liberties Union (ACLU) condemned the ruling as defying "clear science and settled law" and advancing an "anti-abortion agenda." New York Attorney General Letitia James affirmed that abortion access remains legal in her state, vowing to protect it despite the appellate court's order. This stark division highlights the ongoing, deeply polarized debate surrounding reproductive rights in the United States.
In New York, our laws ensure that anyone who needs abortion care can seek it here. That has not changed, and we will continue to protect access to abortion, including medication abortion.
Originally published by Liberty Times in Chinese. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.